These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intention. Petranker R; Anderson T; Maier LJ; Barratt MJ; Ferris JA; Winstock AR J Psychopharmacol; 2022 Jan; 36(1):85-96. PubMed ID: 33591231 [TBL] [Abstract][Full Text] [Related]
5. Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study. van Elk M; Fejer G; Lempe P; Prochazckova L; Kuchar M; Hajkova K; Marschall J Psychopharmacology (Berl); 2022 Jun; 239(6):1705-1720. PubMed ID: 33928421 [TBL] [Abstract][Full Text] [Related]
6. Microdosing psychedelics: Motivations, subjective effects and harm reduction. Lea T; Amada N; Jungaberle H; Schecke H; Klein M Int J Drug Policy; 2020 Jan; 75():102600. PubMed ID: 31778967 [TBL] [Abstract][Full Text] [Related]
7. Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study. Marschall J; Fejer G; Lempe P; Prochazkova L; Kuchar M; Hajkova K; van Elk M J Psychopharmacol; 2022 Jan; 36(1):97-113. PubMed ID: 34915762 [TBL] [Abstract][Full Text] [Related]
8. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting. Prochazkova L; Lippelt DP; Colzato LS; Kuchar M; Sjoerds Z; Hommel B Psychopharmacology (Berl); 2018 Dec; 235(12):3401-3413. PubMed ID: 30357434 [TBL] [Abstract][Full Text] [Related]
9. The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field. Polito V; Liknaitzky P Neurosci Biobehav Rev; 2022 Aug; 139():104706. PubMed ID: 35609684 [TBL] [Abstract][Full Text] [Related]
10. Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research. Polito V; Liknaitzky P J Psychopharmacol; 2024 Jun; ():2698811241254831. PubMed ID: 38877715 [TBL] [Abstract][Full Text] [Related]
11. Microdosing with classical psychedelics: Research trajectories and practical considerations. Wong A; Raz A Transcult Psychiatry; 2022 Oct; 59(5):675-690. PubMed ID: 36317302 [TBL] [Abstract][Full Text] [Related]
13. Perceived harm, motivations for use and subjective experiences of recreational psychedelic 'magic' mushroom use. Roberts CA; Osborne-Miller I; Cole J; Gage SH; Christiansen P J Psychopharmacol; 2020 Sep; 34(9):999-1007. PubMed ID: 32674668 [TBL] [Abstract][Full Text] [Related]
14. Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults. Murray CH; Tare I; Perry CM; Malina M; Lee R; de Wit H Psychopharmacology (Berl); 2022 Jun; 239(6):1735-1747. PubMed ID: 34613430 [TBL] [Abstract][Full Text] [Related]
15. Microdosing psychedelics: personality, mental health, and creativity differences in microdosers. Anderson T; Petranker R; Rosenbaum D; Weissman CR; Dinh-Williams LA; Hui K; Hapke E; Farb NAS Psychopharmacology (Berl); 2019 Feb; 236(2):731-740. PubMed ID: 30604183 [TBL] [Abstract][Full Text] [Related]
16. Motives and Side-Effects of Microdosing With Psychedelics Among Users. Hutten NRPW; Mason NL; Dolder PC; Kuypers KPC Int J Neuropsychopharmacol; 2019 Jul; 22(7):426-434. PubMed ID: 31152167 [TBL] [Abstract][Full Text] [Related]
17. DNA Authentication and Chemical Analysis of Bradshaw AJ; Backman TA; Ramírez-Cruz V; Forrister DL; Winter JM; Guzmán-Dávalos L; Furci G; Stamets P; Dentinger BTM Appl Environ Microbiol; 2022 Dec; 88(24):e0149822. PubMed ID: 36445079 [TBL] [Abstract][Full Text] [Related]
18. Psychedelic microdosing benefits and challenges: an empirical codebook. Anderson T; Petranker R; Christopher A; Rosenbaum D; Weissman C; Dinh-Williams LA; Hui K; Hapke E Harm Reduct J; 2019 Jul; 16(1):43. PubMed ID: 31288862 [TBL] [Abstract][Full Text] [Related]